NCT06125782View on ClinicalTrials.gov

Effect of Omega-3 Fatty Acid on Neurobehavioral Status of Children With Autism Spectrum Disorder: A Randomized, Double-Blind, Placebo Controlled Trial

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 19, 2023

Primary Completion Date

January 30, 2024

Study Completion Date

February 5, 2024

Conditions

Autism Spectrum Disorder

Interventions

DRUG

Omega 3 fatty acid

Omega 3 fatty acid 1 gm softgel capsule- 1 for children at or below 25 kg and two for above 25 kg.

DRUG

Placebo of Omega-3 fatty acid softgel capsule

Placebo of Omega-3 fatty acid softgel capsule- colour and shape almost similar to the original drug- 1 for children at or below 25 kg and 2 for above 25 kg.

Trial Locations (1)

1000

BSMMU, Dhaka

All Listed Sponsors

lead

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

OTHER

NCT06125782 - Effect of Omega-3 Fatty Acid on Neurobehavioral Status of Children With Autism Spectrum Disorder: A Randomized, Double-Blind, Placebo Controlled Trial | Biotech Hunter | Biotech Hunter